Springboard Health Angels

What Springboard Health Angels does

Springboard Health Angels is a Berlin-based angel syndicate founded in 2022 that invests at the seed and pre-seed stages in early-stage health tech and life sciences companies. The firm was established by Dr. Yonathan Goldwasser and Dr. Andreas Schmidt to address a structural gap in Germany's ecosystem between capital providers and the clinical, scientific, and regulatory expertise required to evaluate and scale health technology ventures. The syndicate sources deal flow through a curated network of 40+ active domain experts — including clinicians, scientists, and operators — alongside institutional partnerships with Charité, BIH, Picus Capital, ESMT Berlin, Go-Bio, H3 Health Hub, Bio-cap, GeneNovate, BAND, and the Heidelberg-Mannheim cluster. Since inception, it has executed 30+ strategic investments across computational biology, biopharma infrastructure, digital health, and advanced care models, co-investing alongside top-tier global lead investors such as Frontline Ventures and Y Combinator (as seen in the November 2025 $2.75M seed round into Cellbyte).

The syndicate generates returns through equity stakes in portfolio companies, with monetization occurring via exits, IPOs, or secondary sales. In 2025, Springboard announced a complementary institutional vehicle — Springboard Health Ventures — which is structured as a fund to channel external LP capital (from family offices, Mittelstand industrial companies, pharma corporates, and state-backed innovation investors) into deals vetted by the angel network, adding management fees and carried interest as a recurring revenue stream. Operationally, the firm maintains a small core team (1–10 employees) and deploys capital globally, with deep roots in the DACH region and active cross-border deal access into North America and Israel. The proprietary "asset" is not a software platform but rather the expert network and deal-flow infrastructure that allows it to diligence and support clinically complex ventures faster and more credibly than generalist investors.

Name

Springboard Health Angels

Legal name

Springboard Health Angels GmbH

Website

https://springboardangels.com

Company type

Private

Founded year

2022

Operating status

Operating

Headcount range

1–10 employees

Short description

Berlin-based angel syndicate founded in 2022 that deploys seed and pre-seed capital into early-stage health tech and life sciences companies, backed by a 40+ expert network of clinicians, scientists, and operators.

Ownership category

akta.pro rank

Product category

Venture Capital / Angel Investing

NAICS

Portfolio Management and Investment Advice (523940), Funds, Trusts, and Other Financial Vehicles (525)

SIC

Investment Advice (6282)

akta.pro primary industry

Micro-VC & Angel Funds (FSANAAAI)

Keywords

• Angel investing
• Health tech syndicate
• Venture capital
• Seed funding
• Life sciences investment

Headquarters

HQ city

Berlin

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Investment Returns: Returns generated through equity investments in portfolio companies. Profits realized through exits, IPOs, or secondary sales of portfolio company equity.
2. Fund Management (Springboard Health Ventures): Institutional fund structure bringing together syndicate deal flow under institutional-grade fund. Revenue from management fees and carried interest from fund performance.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

Springboard Health Angels operates an expert syndicate of clinicians, scientists, and operators who deploy capital and domain intelligence at the seed and pre-seed stages of early-stage health tech and life sciences companies. The group complements its syndicate with Springboard Health Ventures, an institutional venture fund (launching soon) that channels capital from external LPs into syndicate-vetted portfolio companies.

Product overview

Springboard Health Angels operates as a two-part offering: (1) the Springboard Health Angels Syndicate — an expert network of clinicians, scientists, and executives who contribute both capital and domain intelligence to evaluate and back early-stage health tech companies at seed and pre-seed stages; and (2) the Springboard Health Ventures Fund — an upcoming institutional venture fund that extends the syndicate's vetted deal flow to external LPs seeking specialist exposure to early-stage health tech and life sciences innovation. Together, these products provide a continuous pipeline from expert judgment to conviction to capital deployment, covering computational biology, biopharma infrastructure, digital health, and advanced care models.

Differentiator

Problem solved

Functional benefit

Brands

• Springboard Health Ventures: The institutional venture fund arm of Springboard Health, launching soon to provide deeper funding to vetted portfolio companies.

Products and services

• Springboard Health Angels Syndicate
• Springboard Health Ventures Fund

Quantifiable outcome

• 30+ strategic investments executed since 2022

Named customers1 record

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Partnerships

Nine partnerships are on record, tiered core and minor.

• CharitécoreStrategic or Co-development PartnerLeading university hospital and medical school in Berlin. Partnership provides access to clinical expertise, research collaboration, and deal flow from academic spin-offs.
• BIH (Berlin Institute of Health)coreStrategic or Co-development PartnerPartnership enables access to translational research and innovation ecosystem in Berlin's health research community.
• ESMT BerlinminorStrategic or Co-development PartnerEuropean School of Management and Technology. Partnership provides business school network and potential deal flow from entrepreneurial programs.
• Go-BiominorStrategic or Co-development PartnerGerman government-backed funding initiative for biotech startups. Partnership may provide co-investment opportunities.
• H3 Health HubminorStrategic or Co-development PartnerHealth innovation hub partnership providing access to startup ecosystem and potential co-investments.
• HGM AdvisoryminorImplementation/ SI/ Consulting PartnerAdvisory partnership providing consulting support for portfolio companies.
• GeneNovateminorStrategic or Co-development PartnerBiotech/life sciences focused partner providing domain expertise and potential deal flow.
• BANDminorStrategic or Co-development PartnerBusiness Angels Deutschland network. Partnership provides access to German angel network and deal flow.
• Heidelberg MannheimminorStrategic or Co-development PartnerHealth/life sciences cluster partnership in the Heidelberg-Mannheim region of Germany.

Scale indicators4 records

Recent moves4 records

Expansion highlights5 records

Direct peers

• Picus Capital: Berlin-based early-stage VC with deep health-tech and digital health focus and a formal co-investment partnership with Springboard. Operates similar seed/pre-seed theses and shares portfolio companies, making it the most directly comparable peer.
• High-Tech Gründerfonds (HTGF): Germany's public-private seed investor covering life sciences and health tech. Operates at the same seed/pre-seed stage and shares the DACH ecosystem, making it a directly comparable specialist.
• b2venture: European health-tech and biotech-focused early-stage VC with a specialized thesis similar to Springboard's. Competes for the same pool of scientific founders in the DACH region.
• Heal Capital: Berlin-based VC exclusively focused on digital health and health-tech companies across Europe. Direct competitor for health-tech seed deals and partnership opportunities in the same ecosystem.
• Asabys Partners: Barcelona-based specialist health-tech and biotech VC investing at seed and Series A in European health innovation. Closely comparable specialist mandate and stage focus.
• Calm/Storm Ventures: European health-tech-focused VC investing across digital health, biotech, and medtech at early stages. Directly comparable thesis, though operating from Austria rather than Germany.
• Digital Health Ventures: Copenhagen-based seed investor specialized in digital health startups across Europe. Comparable specialist thesis and early-stage focus, primarily serving the Nordics.

Broad incumbents

• Earlybird Venture Capital: One of Germany's longest-established VCs with a dedicated health-tech practice. Larger fund sizes and broader sector mandate make it a broad incumbent rather than a direct head-to-head competitor.
• HV Capital: German multi-stage VC with significant health-tech exposure alongside broader tech investing. Broader mandate and larger fund size make it a broad incumbent rather than a pure specialist.
• Boehringer Ingelheim Venture Fund: Corporate venture arm of a global pharma, active in early-stage health-tech and biotech across Europe including DACH. Larger resource base and strategic pharma mandate make it a broad incumbent rather than a pure angel-stage competitor.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/springboard-health-angels
• Xx.com/sprngbrd_angls

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments21 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Springboard Health Angels